Sharing my comment as a post to emphasize a few points:

If telehealth actions limit access, it won’t be because people posted about it.

Discovery rules mean this stuff comes out one way or another when these telehealths get sued and it’ll be the telehealths themselves handing over the evidence of what they’re doing to Lilly.

And besides Reddit posts can’t be used to prove the truth of the matter asserted. They might help build a narrative in a complaint or early filing but they’re not evidence in the case in chief.

I’m more worried about the FDA looking at whether consumers are confused or being misled by marketing.

So if you’re confused don’t be 😂

And if you’re a telehealth, up your disclaimer game like Rift guy does with the whole “not FDA approved” language at the end of every marketing post.

Damn I tried to summarize my main points and it just became basically as long as my original comment 😭😅

Ya know part of me feels guilty for not warning y’all after the April 1st FDA letter came out.

Even as others tried to ease people’s concerns, I read it and understood something had changed, and I quietly ordered 6 months of ProRx from Fifty, increasing my stockpile to about a year.

Still, we can't be sure if this stoppage is related specifically to the FDA's recent moves to rein in compounding and "research" peptides, or isolated to ProRx's operations. We'll know more soon enough I'm sure.

But anyway, to assuage my guilt for not warning y'all before, this is my warning now:

Don't panic, prepare. Whatever that means to you.

I won’t fight anyone in the comments who disagrees with what I'm about to say. I may be an attorney but I really do hate arguing 😂 These are just my thoughts as a tirz user first, and an attorney second, so take it with a grain of salt, but...

I have always disagreed with Big Easy Dave’s lawyers about the latitude the law gives compounders. And Dave/BEWL is not my client, so I have no incentive to find strong favorable legal arguments to advance his business’s objectives.

In my opinion, after reading the FDA letter, I believe the way compounders have been mass producing glp1s for these past couple of years will not continue in the same way. And 503As are not safe.

The fact that Novo is launching vials this year is no coincidence either and should be a hint at what the FDA's new arguments will be when determining what compounded products are essential copies.

Can I envision ways prescribers and pharmacies will change so that we can continue to have wide access? ABSOLUTELY. This is a multibillion dollar industry. Businesses will not be quick to abandon it without a fight. So you can take comfort in that at least.

I can already imagine how many people will suddenly develop allergies to ingredients in Zepbound and medically need compounded tirz with only benzyl alcohol like Hallandale makes 😂

But it’s clear to me, IF the FDA continues what they’ve started, things will change.

Oh and give me some time to edit the pinned post. I'm still waiting to see what all the ProRx telehealths are doing. Basically half the plans are gone 😭😭😭😭😭😭

(Also some "research" peptide sellers, just got FDA warning letters: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters

I recognize Mile High Compounds from TikTok, he's a random guy who buys from China, slaps a label on the vials, and resells them from his house lol so the FDA is certainly paying attention now even to small guys like him)

u/TodayAmazing

⚠️ NOT SO URGENT BUT I WANNA GET IT OUT THERE 😂

ProRx and the future of mass GLP1 compounding: Don't Panic, Prepare.

Don't panic, prepare. Whatever that means to you.